Production (Stage)
NuGen Medical Devices Inc.
NGMDF
$0.043
$0.042942,900.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 197.06% | 199.06% | 307.87% | 373.94% | 214.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 197.06% | 199.06% | 307.87% | 373.94% | 214.89% |
| Cost of Revenue | 181.61% | 188.28% | 422.18% | 400.38% | 172.39% |
| Gross Profit | 213.50% | 210.07% | 226.96% | 350.71% | 274.71% |
| SG&A Expenses | -41.07% | -33.93% | -5.84% | 8.69% | 52.80% |
| Depreciation & Amortization | -10.37% | -7.91% | -18.12% | -8.87% | -1.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.65% | -27.38% | -2.69% | 8.86% | 47.48% |
| Operating Income | 44.04% | 36.69% | 10.67% | -4.53% | -44.03% |
| Income Before Tax | 79.11% | 44.31% | 3.79% | -1.60% | -37.78% |
| Income Tax Expenses | -68.67% | -79.52% | 274.65% | 190.91% | 2,666.67% |
| Earnings from Continuing Operations | 79.07% | 44.44% | 3.48% | -1.82% | -38.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.07% | 44.44% | 3.48% | -1.82% | -38.26% |
| EBIT | 44.04% | 36.69% | 10.67% | -4.53% | -44.03% |
| EBITDA | 47.65% | 39.68% | 9.88% | -6.80% | -48.87% |
| EPS Basic | 81.49% | 57.31% | 38.70% | 41.72% | 28.46% |
| Normalized Basic EPS | 66.08% | 44.36% | 37.13% | 39.37% | 30.58% |
| EPS Diluted | 81.49% | 57.31% | 38.70% | 41.72% | 28.46% |
| Normalized Diluted EPS | 66.08% | 44.36% | 37.13% | 39.37% | 30.58% |
| Average Basic Shares Outstanding | 16.77% | 28.01% | 50.32% | 74.47% | 95.70% |
| Average Diluted Shares Outstanding | 16.77% | 28.01% | 50.32% | 74.47% | 95.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |